-
August 19: The Week in Cancer News
Link found between fracking wells and leukemia in children, and accurate reporting of cancer outcomes urged for Native Hawaiians and Pacific Islanders.
by Kevin McLaughlin
-
August 12: The Week in Cancer News
Drug for HER2-positive cancer receives further approvals, and researchers study the risk of lung cancer from wildfires.
by Marci A. Landsmann
-
August 5: The Week in Cancer News
Study finds majority of patients treated with chemotherapy experience hearing loss, and ‘rogue’ online pharmacies found to be dispensing oncology drugs.
by Thomas Celona
-
July 22: The Week in Cancer News
Drug shortages in hematology oncology, and cancer centers don’t accept Medicaid.
by Marci A. Landsmann
-
July 15: The Week in Cancer News
COVID-19 boosters promote immune response in additional blood cancer patients, and high drug costs lead cancer patients to not fill prescriptions.
by Kevin McLaughlin
-
July 8: The Week in Cancer News
Motherhood does not decrease chance of survival for women who have had breast cancer, and the FDA temporarily suspends ban on Juul e-cigarettes.
by Thomas Celona
-
June 24: The Week in Cancer News
American Cancer Society reacts to Supreme Court decision, and research highlights the disproportionate burden of cancer mortality on Black people.
by Marci A. Landsmann
-
June 17: The Week in Cancer News
Clinical trials rebound after COVID-19 setbacks, and early treatment leads to significant reduction in anal cancer risk among people with HIV.
by Thomas Celona
-
June 10: The Week in Cancer News
Patients who lose weight through bariatric surgery have a lower cancer risk, and a HER2-targeted therapy gets striking results in HER2-low breast cancer patients.
by Kevin McLaughlin
-
June 3: The Week in Cancer News
Contrast dye shortage delays scans for cancer, and more public assistance linked to higher survival rates for Black cancer patients.
by Eric Fitzsimmons
Cancer Talk
Designing Clinical Trials for the Patient
Challenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose